
CAS 2414909-94-5
:Formel:C19H16N6O
InChl:InChI=1S/C19H16N6O/c20-18(26)15-5-3-14(4-6-15)16-12-23-25-9-7-17(24-19(16)25)22-11-13-2-1-8-21-10-13/h1-10,12H,11H2,(H2,20,26)(H,22,24)
InChI Key:LMGXQBQAUALFTB-UHFFFAOYSA-N
SMILES:C1=CC(=CN=C1)CNC2=NC3=C(C=NN3C=C2)C4=CC=C(C=C4)C(=O)N
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
7 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
4-(5-((Pyridin-3-Ylmethyl)Amino)Pyrazolo[1,5-A]Pyrimidin-3-Yl)Benzamide
CAS:4-(5-((Pyridin-3-Ylmethyl)Amino)Pyrazolo[1,5-A]Pyrimidin-3-Yl)BenzamideFormel:C19H16N6OReinheit:>98%Molekulargewicht:344.374-[5-(3-Pyridylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide
CAS:Formel:C19H16N6OReinheit:98%Farbe und Form:SolidMolekulargewicht:344.3699RET V804M-IN-1
CAS:4-(5-((Pyridin-3-ylmethyl)amino)pyrazolo[1,5-a]pyrimidin-3-yl)benzamideFormel:C19H16N6OReinheit:98+%Molekulargewicht:344.37RET V804M-IN-1
CAS:RET V804M-IN-1 (RETV804M kinase inhibitor) is a wt-RET -selective RETV804M kinase inhibitors(IC50 = 20 nM).Formel:C19H16N6OReinheit:97.94% - 99.62%Farbe und Form:White SolidMolekulargewicht:344.36994-(5-((PYRIDIN-3-YLMETHYL)AMINO)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)BENZAMIDE
CAS:Reinheit:98+%Molekulargewicht:344.3779907RET V804M-IN-1
CAS:Selective inhibitor of the mutated RET variant RETV804M, which is the anticipated drug-resistant RET mutant that can occur in tumours treated with kinase inhibitors. The compound has a biochemical IC50 of 0.02 µM and selectivity for purified RETV804M over purified RET and KDR of 3.7 and 110, respectively. The efficacy of the compound was shown also in cell cultures with IC50 of 4.4 µM, and cell assay selectivity for RETV804M over RET and KDR of 0.89 and 2.3, respectively.
Formel:C19H16N6OReinheit:Min. 97 Area-%Farbe und Form:White PowderMolekulargewicht:344.37 g/molRef: 3D-EP176311
Ausgelaufenes produkt





